American Psychiatric Asociation (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Publishing, Washington (D.C.)

Book  Google Scholar 

Ashton CH (1999) Adverse effects of cannabis and cannabinoids. Br J Anaesth 83:637–649. https://doi.org/10.1093/bja/83.4.637

Article  CAS  PubMed  Google Scholar 

Augustin SM, Lovinger DM (2022) Synaptic changes induced by cannabinoid drugs and cannabis use disorder. Neurobiol Dis 167:105670. https://doi.org/10.1016/j.nbd.2022.105670

Article  CAS  PubMed  Google Scholar 

Banasikowski TJ, Hawken ER (2019) The bed nucleus of the stria terminalis, homeostatic satiety, and compulsions: what can we learn from Polydipsia? Frontiers in behavioral neuroscience. https://doi.org/10.3389/fnbeh.2019.00170

Burguière E, Monteiro P, Mallet L et al (2015) Striatal circuits, habits, and implications for obsessive–compulsive disorder. Curr Opin Neurobiol 30:59–65. https://doi.org/10.1016/j.conb.2014.08.008

Article  CAS  PubMed  Google Scholar 

Campos AC, Guimarães FS (2009) Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 33:1517–1521. https://doi.org/10.1016/j.pnpbp.2009.08.017

Article  CAS  PubMed  Google Scholar 

Cooper ZD, Craft RM (2018) Sex-dependent effects of Cannabis and cannabinoids: a translational perspective. Neuropsychopharmacology 43:34–51. https://doi.org/10.1038/npp.2017.140

Article  CAS  PubMed  Google Scholar 

Crystal JD, Maxwell KW, Hohmann AG (2003) Cannabinoid modulation of sensitivity to time. Behav Brain Res 144:57–66. https://doi.org/10.1016/s0166-4328(03)00062-7

Article  CAS  PubMed  Google Scholar 

Deiana S, Watanabe A, Yamasaki Y et al (2011) Plasma and brain pharmacokinetic profile of cannabidiol (CBD), Cannabidivarine (CBDV), ∆9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour. Psychopharmacology 219:859–873. https://doi.org/10.1007/s00213-011-2415-0

Article  CAS  PubMed  Google Scholar 

Díaz-Alonso J, Guzmán M, Galve-Roperh I (2012) Endocannabinoids via CB1receptors act as neurogenic niche cues during cortical development. Philosophical Trans Royal Soc B: Biol Sci 367:3229–3241. https://doi.org/10.1098/rstb.2011.0385

Article  CAS  Google Scholar 

Didriksen M, Olsen GM, Christensen AV (1993) Effect of clozapine upon schedule-induced polydipsia (SIP) resembles neither the actions of dopamine D1 nor D2 blockade. Psychopharmacology 113:250–256. https://doi.org/10.1007/bf02245706

Article  CAS  PubMed  Google Scholar 

Falk JL (1966) Schedule-induced polydipsia as a function of fixed interval length1. J Exp Anal Behav 9:37–39. https://doi.org/10.1901/jeab.1966.9-37

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falk JL (1971) The nature and determinants of adjunctive behavior. Physiol Behav 6:577–588. https://doi.org/10.1016/0031-9384(71)90209-5

Article  CAS  PubMed  Google Scholar 

Fernandez-Cabrera MR, Higuera-Matas A, Fernaud-Espinosa I, DeFelipe J, Ambrosio E, Miguens M (2018) Selective effects of ∆9-tetrahydrocannabinol on medium spiny neurons in the striatum. PLoS ONE, 13(7), e0200950

Fineberg NA, Potenza MN, Chamberlain SR et al (2010) Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 35:591–604. https://doi.org/10.1038/npp.2009.185

Article  PubMed  Google Scholar 

Fineberg NA, Apergis-Schoute AM, Vaghi MM et al (2018) Mapping compulsivity in the DSM-5 obsessive compulsive and related disorders: cognitive domains, neural circuitry, and treatment. Int J Neuropsychopharmacol 21:42–58. https://doi.org/10.1093/ijnp/pyx088

Article  CAS  PubMed  Google Scholar 

Flores P, Pellón R (1997) Effects of D-amphetamine on temporal distributions of schedule-induced polydipsia. Pharmacol Biochem Behav 57:81–87. https://doi.org/10.1016/s0091-3057(96)00131-1

Article  CAS  PubMed  Google Scholar 

Franklin ME, Foa EB (2011) Treatment of obsessive compulsive disorder. Ann Rev Clin Psychol 7:229–243. https://doi.org/10.1146/annurev-clinpsy-032210-104533

Article  Google Scholar 

Fuentes-Verdugo E, López-Tolsa GE, Pellón R, Miguéns M (2022) Chronic ∆-9-Tetrahydrocannabinol administration delays acquisition of schedule-induced drinking in rats and retains long-lasting effects. Psychopharmacology 239:1359–1372. https://doi.org/10.1007/s00213-021-05952-2

Article  CAS  PubMed  Google Scholar 

Gomes FV, Casarotto PC, Resstel LBM, Guimarães FS (2011) Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice. Prog Neuropsychopharmacol Biol Psychiatry 35:434–438. https://doi.org/10.1016/j.pnpbp.2010.11.027

Article  CAS  PubMed  Google Scholar 

Goodman J, Packard MG (2015) The influence of cannabinoids on learning and memory processes of the dorsal striatum. Neurobiol Learn Mem 125:1–14. https://doi.org/10.1016/j.nlm.2015.06.008

Article  CAS  PubMed  Google Scholar 

Gorberg V, McCaffery P, Anavi-Goffer S (2020) Different responses of repetitive behaviours in juvenile and young adult mice to ∆9‐tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome. Br J Pharmacol 178:614–625. https://doi.org/10.1111/bph.15302

Article  CAS  PubMed  Google Scholar 

Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327–360. https://doi.org/10.2165/00003088-200342040-00003

Article  CAS  PubMed  Google Scholar 

Gutiérrez-Ferre VE, Pellón R (2019) Wheel running induced by intermittent food schedules. Psicológica J 40:46–61. https://doi.org/10.2478/psicolj-2019-0004

Article  Google Scholar 

Han CJ, Robinson JK (2001) Cannabinoid modulation of time estimation in the rat. Behav Neurosci 115:243–246. https://doi.org/10.1037/0735-7044.115.1.243

Article  CAS  PubMed  Google Scholar 

Harkany T, Guzmán M, Galve-Roperh I et al (2007) The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28:83–92. https://doi.org/10.1016/j.tips.2006.12.004

Article  CAS  PubMed  Google Scholar 

Hoffman AF et al (2021) Impairment of synaptic plasticity by cannabis, Delta (9)-THC, and synthetic cannabinoids. Cold Spring Harb Perspect Med 11. https://doi.org/10.1101/cshperspect.a039743

Hogg S, Dalvi A (2004) Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists. Pharmacol Biochem Behav 77:69–75. https://doi.org/10.1016/j.pbb.2003.09.020

Article  CAS  PubMed  Google Scholar 

Huestis MA (2007) Human cannabinoid pharmacokinetics. Chem Biodivers 4:1770–1804. https://doi.org/10.1002/cbdv.200790152

Article  CAS  PubMed  PubMed Central  Google Scholar 

Íbias J, Soria-Molinillo E, Kastanauskaite A et al (2015) Schedule-induced polydipsia is associated with increased spine density in dorsolateral striatum neurons. Neuroscience 300:238–245. https://doi.org/10.1016/j.neuroscience.2015.05.026

Article  CAS  PubMed  Google Scholar 

Íbias J, Miguéns M, Pellón R (2016) Effects of dopamine agents on a schedule-induced polydipsia procedure in the spontaneously hypertensive rat and in wistar control rats. J Psychopharmacol 30:856–866. https://doi.org/10.1177/0269881116652598

Article  CAS  PubMed  Google Scholar 

Íbias J, Daniels CW, Miguéns M et al (2017) The effect of methylphenidate on the microstructure of schedule-induced polydipsia in an animal model of ADHD. Behav Brain Res 333:211–217. https://doi.org/10.1016/j.bbr.2017.06.048

Article  CAS  PubMed  Google Scholar 

Ioannidis K, Chamberlain SR, Treder MS et al (2016) Problematic internet use (PIU): associations with the impulsive-compulsive spectrum. An application of machine learning in psychiatry. J Psychiatr Res 83:94–102. https://doi.org/10.1016/j.jpsychires.2016.08.010

Article  PubMed  PubMed Central  Google Scholar 

Iversen L (2003) Cannabis and the brain. Brain 126:1252–1270. https://doi.org/10.1093/brain/awg143

Article  PubMed  Google Scholar 

Kayser RR, Snorrason I, Haney M et al (2019) The endocannabinoid system: a new treatment target for obsessive compulsive disorder? Cannabis Cannabinoid Res 4:77–87. https://doi.org/10.1089/can.2018.0049

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kayser RR, Raskin M, Snorrason I, Hezel DM, Haney M, Simpson HB (2020) Cannabinoid augmentation of exposure-based psychotherapy for obsessive-compulsive disorder. J Clin Psychopharmacol 40:207–210. https://doi.org/10.1097/jcp.0000000000001179

Kesner AJ, Lovinger DM (2020) Cannabinoids, endocannabinoids and sleep. Front Mol Neurosci 13:125. https://doi.org/10.3389/fnmol.2020.00125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Killeen PR, Fetterman JG (1988) A behavioral theory of timing. Psychol Rev 95:274–295. https://doi.org/10.1037/0033-295x.95.2.274

Article